ROC analysis revealed that uEV‐AQP1 and ‐AQP2 reflected CKD progression of G4 and above, and particularly, the use of both uEV‐proteins in combination yielded better results than the use of either protein alone. Here, AQP2 is linked to chronic kidney disease.